The Barrow Neurological Institute is proud of its reputation as a medical research facility and is home to some of the most sophisticated research programs outside of an academic setting in the Southwestern United States. Researchers in the Barrow Neurosurgery Research Center are devoted to learning more about the causes of and treatments for a wide range of disorders, such as stroke, aneurysms, spinal cord injury, and hydrocephalus. Our research has led to treatments that are being used around the world. Within the Department are neurosurgeons who subspecialize in cerebrovascular and skull base, functional and stereotactic, pediatric, spine, tumor, and endovascular neurosurgery.
Physicians, scientists, and expert clinical staff come together with a commitment to developing new techniques for the prevention, diagnosis, treatment, and rehabilitation of neurological illnesses and injuries. The leadership of internationally respected physicians keeps Barrow at the forefront of neuroscience. The compassionate expertise of its extensive staff of nurses, technologists, therapists and support personnel is evident in every aspect of care provided.
Our mission is to advance the knowledge and practice of medicine in neuroscience through basic and clinical research, education of medical professionals, and innovation in clinical techniques and technology.
Submissions from 2024
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study., Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, María José Méndez-Vidal, Evgeny Kopyltsov, Sergei Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi McKenzie, Toni K Choueiri, and Rob Galamaga
Submissions from 2023
Ergonomic Analysis of Otologic Surgery: Comparison of Endoscope and Microscope, Annie E. Arrighi-Allisan, Caleb J. Fan, Kevin Wong, Anni Wong, Katherine L. Garvey, Zachary G. Schwam, Peter Filip, Ameya A. Jategaonkar, Enrique Perez, George B. Wanna, Satish Govindaraj, Alfred-Marc Iloreta, and Maura K. Cosetti
Durable and dramatic response to checkpoint inhibition combined with COX-2 inhibitor celecoxib in a patient with p16+ metastatic sinonasal undifferentiated carcinoma: A case study, Jonathan Q. Trinh, Cassaundra Acosta, Arti Easwar, Robert Galamaga, and Alan Tan
Submissions from 2021
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma., Toni K Choueiri, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Thomas Ferguson, Yen-Hwa Chang, Jaroslav Hajek, Stefan N Symeonides, Jae Lyun Lee, Naveed Sarwar, Antoine Thiery-Vuillemin, Marine Gross-Goupil, Mauricio Mahave, Naomi B Haas, Piotr Sawrycki, Howard Gurney, Christine Chevreau, Bohuslav Melichar, Evgeniy Kopyltsov, Ajjai Alva, John M Burke, Gurjyot Doshi, Delphine Topart, Stephane Oudard, Hans Hammers, Hiroshi Kitamura, Jens Bedke, Rodolfo F Perini, Pingye Zhang, Kentaro Imai, Jaqueline Willemann-Rogerio, David I Quinn, Thomas Powles, and Rob Galamaga
Implementation of a 4-dimensional computed tomography protocol for parathyroid adenoma localization, Ameya A. Jategaonkar, David K. Lerner, Peter Cooke, Diana Kirke, Eric M. Genden, and Samuel J. Trosman
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma., Robert Motzer, Boris Alekseev, Sun-Young Rha, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E Hutson, Evgeny Kopyltsov, María J Méndez-Vidal, Vadim Kozlov, Anna Alyasova, Sung-Hoo Hong, Anil Kapoor, Teresa Alonso Gordoa, Jaime R Merchan, Eric Winquist, Pablo Maroto, Jeffrey C Goh, Miso Kim, Howard Gurney, Vijay Patel, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Bohuslav Melichar, Frederic Rolland, Ugo De Giorgi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Corina E Dutcus, Alan D Smith, Lea Dutta, Kalgi Mody, Rodolfo F Perini, Dongyuan Xing, Toni K Choueiri, and Rob Galamaga
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial., Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, Nobuaki Matsubara, Lajos Géczi, Susanna Y-S Cheng, Yves Fradet, Stephane Oudard, Christof Vulsteke, Rafael Morales Barrera, Aude Fléchon, Seyda Gunduz, Yohann Loriot, Alejo Rodriguez-Vida, Ronac Mamtani, Evan Y Yu, Kijoeng Nam, Kentaro Imai, Blanca Homet Moreno, Ajjai Alva, and Rob Galamaga
Submissions from 2020
Unexpected high-risk pathologic features following thyroidectomy in the chinese immigrant population, Arvind K. Badhey, Erin Moshier, Ameya Jategaonkar, Anni Wong, Kristen Echanique, and Raymond L. Chai
Surgery of the Palatomaxillary Structure, Ameya A. Jategaonkar, Vivian F. Kaul, Eric Lee, and Eric M. Genden
Staying ahead of the curve: Early lessons from a New York City Otolaryngology Department's organizational response to the coronavirus pandemic, Zachary G. Schwam, Ameya A. Jategaonkar, Marita S. Teng, Scott Horn, Robert S. Lebovics, Eric M. Genden, and George B. Wanna
Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study, Nicholas J. Vogelzang, Mark R. Olsen, Joshua J. McFarlane, Edward Arrowsmith, Todd M. Bauer, Rohit K. Jain, Bradley Somer, Elaine T. Lam, Mark D. Kochenderfer, Ana Molina, Gurjyot Doshi, Brian Lingerfelt, Ralph J. Hauke, Vijay Gunuganti, Ian Schnadig, Peter Van Veldhuizen, Mark Fleming, Robert Galamaga, Mukul Gupta, Hugo Hool, Thomas Hutson, Joshua Zhang, M Brent McHenry, Jennifer L. Johansen, and Scott S. Tykodi
Submissions from 2019
Regional Reconstruction of Orbital Exenteration Defects, Ameya A. Jategaonkar, Dominic Vernon, and Patrick J. Byrne
Syphilis of the oropharynx: Case series of "The Great Masquerader", Ameya Jategaonkar, Jaclyn Klimczak, Jay Agarwal, Arvind Badhey, William M. Portnoy, Angela Damiano, and Raymond L. Chai
TORS excision of lingual thyroid carcinoma: Technique and systematic review, Aurora Vincent, Ameya Jategaonkar, Sameep Kadakia, and Yadranko Ducic
Submissions from 2018
Total mandibulectomy defect in the setting of chronic bisphosphonate use, Ameya A. Jategaonkar, Arvind K. Badhey, Mofiyinfolu Sokoya, Sameep Kadakia, Steven Mudrovich, and Yadranko Ducic
Tonsillectomy sparing transoral robot assisted styloidectomy, Sameep Kadakia, Ameya Jategaonkar, Ansley Roche, and Raymond L. Chai
Septic arthritis of the sternoclavicular joint: A unique late complication after tracheostomy, Kayvon F. Sharif, Fred M. Baik, Ameya A. Jategaonkar, Azita S. Khorsandi, and Mark L. Urken
Holmium Laser for Endoscopic Treatment of Benign Tracheal Stenosis, D J. Verret, Ameya Jategaonkar, Samuel Helman, Sameep Kadakia, Arash Bahrami, Eli Gordin, and Yadranko Ducic
Submissions from 2017
Eagle syndrome: A comprehensive review, Arvind Badhey, Ameya Jategaonkar, Alexander Joseph Anglin Kovacs, Sameep Kadakia, Peter Paul De Deyn, Yadranko Ducic, Stimson Schantz, and Edward Shin
Scar Revision: Surgical and Nonsurgical Options, Sameep Kadakia, Yadranko Ducic, Ameya Jategaonkar, and David Chan
Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study, Moustafa Mourad, Thomas Jetmore, Ameya A. Jategaonkar, Sami Moubayed, Erin Moshier, and Mark L. Urken
Intraoperative nerve monitoring during parathyroid surgery: The Fort Worth experience, Moustafa Mourad, Sameep Kadakia, Ameya Jategaonkar, Eli Gordin, and Yadranko Ducic
Submissions from 2016
Management of rhinosinusitis during pregnancy: systematic review and expert panel recommendations, Devyani Lal, Ameya A. Jategaonkar, Larry Borish, Linda R. Chambliss, Sharon H. Gnagi, Peter H. Hwang, Matthew A. Rank, James A. Stankiewicz, and Valerie J. Lund
Submissions from 2015
Factors predicting survival in peripheral T-cell lymphoma in the USA: a population-based analysis of 8802 patients in the modern era, Adam M. Petrich, Irene B. Helenowski, Locke J. Bryan, Shaina A. Rozell, Robert Galamaga, and Chadi Nabhan